KOLINPHARMA® obtains a patent in the United States of America for Dolatrox® - 10/03/202025 May 2020
Dolatrox® is a composition for the treatment of arthropathies and osteoarthritis, as stated in the patent certificate. This composition was thus recognized as innovative and unique. Dolatrox is the 4th patent that Kolinpharma obtains in the USA.
"Obtaining the fourth patent, in a country like the United States, a worldwide reference in scientific research, is a huge source of pride for us" - comments the president, Rita Paola Petrelli.
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation